Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
about
Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motilityVibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher responseSafety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels.Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteersSafety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India.Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccinePreliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccinationRandomized, controlled human challenge study of the safety, immunogenicity, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine.In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animalsAntibody responses in serum, secretions, and urine of man after parenteral administration of vaccines.Immunity to Vibrio cholerae in the mouse. I. Passive protection of newborn miceRadiobacteriolysis: a new technique using chromium-51 for assaying anti-Vibrio cholerae antibodies.Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin.Active and passive immunization in the adult rabbit ileal loop model as an assay for production of antitoxin immunity by cholera vaccinesAttenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.Microbiological surveillance of intra-neighbourhood E1 Tor cholera transmission in rural Bangladesh.Furazolidone in paediatric cholera.Report of the 1966-67 cholera vaccine trial in rural East Pakistan.Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observationSerological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic choleraA serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera.Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio choThe relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor.Genomic correlates of variability in immune response to an oral cholera vaccine.Case report of Plesiomonas shigelloides-associated persistent dysentery and pseudomembranous colitis.Evaluation of the card test for diagnosis of human brucellosis.Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.Antibody-Based Correlates of Protection Against Cholera Analysis of a Challenge Study in a Cholera-Naïve Population.Serological response to cholera revaccination in a semi-closed community in CalcuttaImmunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin.Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638.
P2860
Q30496874-2F87D8D1-9DBF-41D7-96F3-BD75A81754EDQ33598485-642B17EE-7BB6-4BD8-9B3E-653E92E5D2EAQ33601858-FD14000F-C00B-48FD-993B-F7355CFD7C9AQ33606727-73E7B6D4-9302-4EDB-886E-9D438E0A6BCEQ33609081-C9123AC1-7EAD-40B4-BADE-4E7AFBF4A082Q33756057-5339A258-697A-4B92-9FCE-03AAC2881E4BQ33768926-D411B00D-05D3-4129-8A69-AAA2ACA3B155Q33830466-BBACA36B-77D9-43C1-AFC9-A4FE1631AB7EQ33910000-A4429CCD-B9B8-4B56-9553-E3AFDEB5D75CQ34000153-2C30911E-4AF2-4970-B2BC-36A8A21C3361Q34002698-9C904D47-AC00-47D1-BEC5-35C4F0CC13D7Q34121025-08EE9106-2F47-4872-8E21-4A43E4B7AFF1Q34152883-B69F6A4F-4DC7-4957-9E6C-C7B99FFD5AC6Q34157361-7B6BD4E7-5E8F-404F-9878-633A0CA37B45Q34470337-5A998F9E-68A0-45D8-95A4-4B198C0368EFQ34482133-A3C28F8B-E934-4020-865F-1DDA1C2550F6Q34504548-B2C2D88E-672F-45F0-9604-34355BFA560BQ35158730-41BA7B2A-7934-4463-ACC5-6B662670E1A3Q35388488-BE6CBDBB-2DEE-4DA3-B16C-E8D9AECEB02CQ36551627-E09961BA-6F36-46A1-AD49-40D60A75697BQ36675319-8127B983-3BE1-4EE1-A1E2-3456FCEB6E2BQ36720024-9123E00F-57EB-4DEA-9F6B-2C83754CFE08Q36785801-9C705873-DED4-49EA-9254-9486DD276107Q36785879-9DA4A2C6-6BE5-42FA-9D6B-CDC4EFC5A980Q36910766-23754FD2-546A-45F4-A0DF-941606A77016Q36911175-5A7FDC09-984D-4A22-926D-13118A95CF30Q36911188-9755C6E9-7431-463A-A7CC-EBA4251CF821Q36911199-D2E5AE4B-0DD6-40BA-A23C-1B36BDBA3916Q36911502-BAC6CD7A-E49B-4B49-BD52-AA51D585ED2DQ36911515-4922DAF1-9895-443E-B84E-018D0139A8FEQ36911671-0FFB07A9-9B9A-4C97-A2B6-B1FF44A772BFQ36915108-8FB97A2F-EDD8-42E9-8E8C-8611C5B31D2DQ37102102-18A88867-7D6E-4AF8-8C24-06EF67E70B61Q37179173-306F8F69-E898-4A67-B68A-9DF45D0BD1E7Q37360302-6363FFE0-8534-4660-8BAE-39A5AE626A0FQ37544964-6896CD5A-0279-4BDE-949E-45CA04556E87Q38752684-CF1C9E0E-B2F1-4E4A-A48D-5F0DFBAAB22CQ39150410-507086FC-F7E3-447C-BDFE-1B2A8037F6F8Q39250338-4CFA04B0-571A-4B93-AF7B-7FF9F6836ADCQ39516930-C63B8C2E-4CC5-4131-8657-71296CA11769
P2860
Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
1968年论文
@zh
1968年论文
@zh-cn
name
Serological studies in cholera ...... etermined by a microtechnique.
@en
type
label
Serological studies in cholera ...... etermined by a microtechnique.
@en
prefLabel
Serological studies in cholera ...... etermined by a microtechnique.
@en
P2093
P1476
Serological studies in cholera ...... etermined by a microtechnique.
@en
P2093
P2860
P304
P407
P577
1968-01-01T00:00:00Z